CMS has modernized Medicare coverage for transcatheter aortic valve replacement, ending evidence-development requirements for symptomatic severe aortic stenosis while creating a pathway for certain asymptomatic patients.
CareDx reports Q2 results on July 30 as investors assess transplant testing growth, Medicare coverage clarity and the Naveris strategy.
Medicare coverage gives ColoSense a bigger test: can stool RNA screening move from FDA approval to real colorectal cancer adoption?
Find out how Pacira BioSciences, Inc.’s EXPAREL data could reduce opioid use and surgical costs in Medicare patients.